Publications
Found 2 results
Filters: author is Holopainen [Clear All Filters]
2008
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis
Heckman, C.A.; Holopainen, T.; Wirzenius, M.; Keskitalo, S.; Jeltsch, M.; Ylä-Herttuala, S.; Wedge, S.R.; Jürgensmeier, J.M.; Alitalo, K.
, Cancer Research, Volume 68, p.4754-62, (2008)
Abstract
2005
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry
He, Y.; Rajantie, I.; Pajusola, K.; Jeltsch, M.; Holopainen, T.; Yla-Herttuala, S.; Harding, T.; Jooss, K.; Takahashi, T.; Alitalo, K.
, Cancer Res, Volume 65, Issue 11, Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Biomedicum Helsinki and Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland, p.4739-46, (2005)
Abstract